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Results. Babies at term predominated - 87.8% of cases, respectively 88.2% of cases (p>0.05). 
The percentage of premature neonates was 12.2% versus 10.1% in the control group (p>0.05). 
The mean birth weight was 3135.6 ± 67.2g versus 3216.1 ± 54.3g in the control group (p>0.05). 
The neonatal morbidity rate in the study group was 49.4% compared to 22.7% in the control 
group (p<0.001). The intrauterine growth restriction of the fetus was identified in every 4th child 
born in the study group (24.7% vs. 12.6%, p<0.05). There were 24.7% cases of perinatal EHI 
(hypoxic-ischemic encephalopathy) compared with 11.8% in the control group(p<0.05). The 
incidence of intrauterine infections in neonates was 11.1% compared to 0% in the control 
group(p<0.01).  
Conclusions. The newborns of patients with active tuberculosis of the respiratory organs showed 
a high percentage of perinatal pathology, ante- and intranatal hypoxia, prematurity, intrauterine 
growth restriction of the fetus, forming the high-risk group for the development of EHI perinatal 
involvement, with a complicated evolution of the early neonatal period.  
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Introduction. Borderline ovarian tumors (BOT) are malignant epithelial ovarian tumors with a 
very low incidence, therefore lacking sufficient clinical experience in diagnostics and treatment.  
Aim of the study. This study characterized the histology, clinical features, diagnostics and 
therapy of BOT including patients treated at the Department of Oncogynecology of the Nicolae 
Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova. 
Materials and methods. In this retrospective study, patients with BOT treated between 2000 
and 2016 were analyzed according to their histological and clinical reports.  
Results. A total of 45 patients were enrolled. The median age was 45.6(range=18-83) years. 
Distribution of histological subtypes was: serous in 31 patients (57.4 %) and mucinous in 14 
patients (42.6%). All patients underwent surgery and 6 patients (14.8%) were treated according 
to actual therapy recommendations during the initial surgery. Six patients (14.8%) received 
adjuvant chemotherapy contrary to treatment recommendations. In the case of 30 patients 
(66.7%), the definitive histological result matched in 88.9%. During average follow-up of 30.3 
months (range=0-115,5 months), 6 patients (14.8%) developed tumor recurrence after 9 and 29 
months, respectively, two patients (3.7%) died of causes other than BOT.  
Conclusions. Our study critically demonstrated that until a few years ago, BOTs were not 
usually treated according to international therapy recommendations chemotherapy and surgery. 
The rate of tumor recurrence was very low. 
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